Kazuhira Miki

发表

Optimising first- and second-line treatment strategies for untreated major depressive disorder — the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial

G. Guyatt, Y. Okamoto, T. Furukawa, 2018, BMC Medicine.

Prediction of remission in pharmacotherapy of untreated major depression: development and validation of multivariable prediction models

T. Furukawa, H. Fujita, M. Inagaki, 2018, Psychological Medicine.

Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol

T. Furukawa, N. Yonemoto, N. Watanabe, 2011, Trials.

The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase

T. Furukawa, N. Yonemoto, N. Watanabe, 2012, Trials.

Whose depression deteriorates during acute phase antidepressant treatment?

T. Furukawa, N. Yonemoto, Y. Ogawa, 2019, Journal of affective disorders.

Title Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression ( FLATT project ) : Study protocol for a randomized controlled trial

T. Furukawa, N. Yonemoto, N. Watanabe, 2019 .

Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial

Toshi A. Furukawa, Aran Tajika, Norio Watanabe, 2015, Trials.

Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan

G. Guyatt, T. Furukawa, N. Yonemoto, 2015, Trials.